Prognostic relevance of minimal residual disease in colorectal cancer

被引：31

作者：

Bork, Ulrich ^{[1
]}

Gruetzmann, Robert ^{[1
]}

Rahbari, Nuh N. ^{[1
]}

Schoelch, Sebastian ^{[1
]}

Distler, Marius ^{[1
]}

Reissfelder, Christoph ^{[1
]}

Koch, Moritz ^{[1
]}

Weitz, Juergen ^{[1
]}

机构：

[1] Tech Univ Dresden, Dept GI Thorac & Vasc Surg, Univ Hosp Dresden, D-01307 Dresden, Germany

来源：

WORLD JOURNAL OF GASTROENTEROLOGY | 2014年 / 20卷 / 30期

关键词：

Colorectal cancer; Circulating tumor cells; Disseminated tumor cells; Isolated tumor cells; Micrometastases; Occult disease; Minimal residual disease; CIRCULATING TUMOR-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; METASTATIC COLON-CANCER; PERIPHERAL-BLOOD; BREAST-CANCER; LYMPH-NODES; BONE-MARROW; MODEL; MICE; DISSEMINATION;

D O I：

10.3748/wjg.v20.i30.10296

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Presence of occult minimal residual disease in patients with colorectal cancer (CRC) has a strong prognostic impact on survival. Minimal residual disease plays a major role in disease relapse and formation of metastases in CRC. Analysis of circulating tumor cells (CTC) in the blood is increasingly used in clinical practice for disease monitoring of CRC patients. In this review article the role of CTC, disseminated tumor cells (DTC) in the bone marrow and micrometastases and isolated tumor cells (ITC) in the lymph nodes will be discussed, including literature published until September 2013. Occult disease is a strong prognostic marker for patient survival in CRC and defined by the presence of CTC in the blood, DTC in the bone marrow and/or micrometastases and ITC in the lymph nodes. Minimal residual disease could be used in the future to identify patient groups at risk, who might benefit from individualized treatment options. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.

引用

页码：10296 / 10304

页数：9

共 69 条

[1] Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].

Allard, WJ ;

Matera, J ;

Miller, MC ;

Repollet, M ;

Connelly, MC ;

Rao, C ;

Tibbe, AGJ ;

Uhr, JW ;

Terstappen, LWMM .

CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904

[2]

[Anonymous], 1869, Aust Med J

[3] Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies [J].

Antolovic, Dalibor ;

Galindo, Luis ;

Carstens, Anina ;

Rahbari, Nuh ;

Buechler, Markus W. ;

Weitz, Juergen ;

Koch, Moritz .

BMC BIOTECHNOLOGY, 2010, 10

[4]

BRESALIER RS, 1987, CANCER RES, V47, P1398

[5] Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood [J].

Chang, YS ;

di Tomaso, E ;

McDonald, DM ;

Jones, R ;

Jain, RK ;

Munn, LL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (26) :14608-14613

[6] Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel [J].

Cheng, George Z. ;

Chan, Joseph ;

Wang, Qi ;

Zhang, Weizhou ;

Sun, Calvin D. ;

Wang, Lu-Hai .

CANCER RESEARCH, 2007, 67 (05) :1979-1987

[7] Concomitant BRAF and PI3K/mTOR Blockade Is Required for Effective Treatment of BRAFV600E Colorectal Cancer [J].

Coffee, Erin M. ;

Faber, Anthony C. ;

Roper, Jatin ;

Sinnamon, Mark J. ;

Goel, Gautam ;

Keung, Lily ;

Wang, Wei Vivian ;

Vecchione, Loredana ;

de Vriendt, Veerle ;

Weinstein, Barbara J. ;

Bronson, Roderick T. ;

Tejpar, Sabine ;

Xavier, Ramnik J. ;

Engelman, Jeffrey A. ;

Martin, Eric S. ;

Hung, Kenneth E. .

CLINICAL CANCER RESEARCH, 2013, 19 (10) :2688-2698

[8] Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer [J].

Cohen, S. J. ;

Punt, C. J. A. ;

Iannotti, N. ;

Saidman, B. H. ;

Sabbath, K. D. ;

Gabrail, N. Y. ;

Picus, J. ;

Morse, M. A. ;

Mitchell, E. ;

Miller, M. C. ;

Doyle, G. V. ;

Tissing, H. ;

Terstappen, L. W. M. M. ;

Meropol, N. J. .

ANNALS OF ONCOLOGY, 2009, 20 (07) :1223-1229

[9] Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer [J].

Cohen, Steven J. ;

Punt, Cornelis J. A. ;

Iannotti, Nicholas ;

Saidman, Bruce H. ;

Sabbath, Kert D. ;

Gabrail, Nashat Y. ;

Picus, Joel ;

Morse, Michael ;

Mitchell, Edith ;

Miller, M. Craig ;

Doyle, Gerald V. ;

Tissing, Henk ;

Terstappen, Leon W. M. M. ;

Meropol, Neal J. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3213-3221

[10]

CORBETT TH, 1975, CANCER RES, V35, P2434

← 1 2 3 4 5 6 7 →